Author name: Leonardo Arias

Looking for a manufacturing job? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.

The past year saw manufacturing challenges pushed into the spotlight. BioSpace spoke to two executives who shared key issues facing those working in this area, from finding the right providers to dealing with regulatory uncertainty.

La diabetes mellitus es una de las enfermedades crónicas más prevalentes del siglo XXI. Según la Organización Mundial de la Salud, afecta a cientos de millones de personas en todo el mundo y su incidencia no deja de crecer. Sin embargo, más allá de las cifra …

Venture funds attending the J.P. Morgan Healthcare Conference said mounting funding pressures and Chinese competition have sharpened their focus on leadership qualities, from regulatory expertise and industry experience to the ability to scale—or step aside—as companies mature.

The U.S. spent 7.2% more on healthcare in 2024. Most of the acceleration was because of greater use and intensity of medical goods and services, not growth in healthcare prices, CMS actuaries said.

Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P. Morgan presentation: its oncology portfolio is underappreciated. This week, the Illinois-based company dove into the sizzling PD-1/VEGF space with a licensing deal with China-based RemeGen.

The insurer will cut its MA payment timelines in half for select providers in Oklahoma, Idaho, Minnesota and Missouri in an effort to provide relief to rural hospitals.

Buying vaccine biotech Dynavax was an easy choice for Sanofi despite antivaccine moves by the Trump administration.

At a J.P. Morgan media event Tuesday, the Gilead C-suite seemed to be walking on air as they highlighted Yeztugo’s capture of the HIV market and its plans for business development.

Workers at the National Institute for Occupational Safety and Health affected by the layoffs last spring received emails yesterday that their reduction-in-force notices have been revoked. Hundreds of NIOSH employees had been let go.